In our in vitro study, by overexpressing and inhibiting SIRT4 gene in prostate cancer cells, we demonstrated that SIRT4 could significantly inhibit cell proliferation, migration, invasion capabilities, and cell cycle of prostate cancer cells. This evidence concerns the gene SIRT4 and prostate carcinoma.